Patent ID: 8883730

Claim:
A method for treating an eosinophil mediated disorder comprising administering a formulation comprising human Surfactant Protein-D (SP-D) to a subject in need thereof, wherein the eosinophil mediated disorder is eosinophilic cardiomyopathy, eosinophilic gastroenteritis, graft versus host disease, drug reaction, eosinophilic pneumonia, episodic angioedema with eosinophilia, inflammatory bowel disease, eosinophilic leukemia, food enteropathy, neuromuscular disease with eosinophilia, eosinophilia-Myalgia syndrome, eosinophilic fascitis, capillary leak syndrome, Churg-Strauss syndrome, toxic oil syndrome, chronic sinusitis, cirrhosis or two or more thereof.